Close
聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽
The Day Lab is based in the 香港六合彩中特网 Division of Medicine. It forms part of the Centre for Precision Healthcare and the Department of Ageing, Rheumatology and Regenerative Medicine.
The Day Lab has a sustained track record in the creation and clinical testing of new technology applied to regenerative medicine. This spans invention, development, public engagement, clinical translation and commercialisation. Notable achievements include pioneering聽clinical聽translation of a novel class III medical device, consisting of a biomaterial developed by the group, into an MHRA approved Phase I/IIb trial (this is 香港六合彩中特网's first regulated trial for a novel biomaterial) and the EU funded AMELIE project (), which is 香港六合彩中特网鈥檚 largest, most ambitious translational tissue engineering study to date comprising of a 香港六合彩中特网 invented tissue engineered product being investigated in a clinical trial involving patients from six聽European countries.
The Day Lab conducts internationally-leading research in areas associated with bowel disorders, cardiovascular disease, cancer, ophthalmology, antimicrobial resistance, and bioprocessing聽for cell delivery, and is supported by cross-disciplinary research collaborations with other 香港六合彩中特网 groups in the Faculties of Engineering (Department of Mechanical Engineering), Life Sciences (Division of Biosciences, School of Pharmacy), Mathematical & Physical Sciences (Chemistry Department, Physics & Astronomy Department), Institute of Cardiovascular Science (The Hatter Cardiovascular Institute), Institute of Opthalmology, and Medical Sciences (Eastman聽Dental Institute, Division of Surgery), as well as clinical, surgical and nursing collaborations at the affiliated University College London Hospital.
The group works closely with the 香港六合彩中特网 Translational Research Office, 香港六合彩中特网 Innovation & Enterprise, 香港六合彩中特网 Consultants Ltd, and 香港六合彩中特网 Business Ltd to facilitate clinical translation and commercialization of our exciting and innovative technology.
This site contains up to date information on the current activities of the group.聽聽
